Retinal Vein Occlusion Recruiting Phase 4 Trials for Ranibizumab (DB01270)

Also known as: Occlusion Retinal Vein / Retinal-vein occlusion / Retinal Vein Occlusions(RVO) / Retinal Vein Occlusion (RVO) / Retinal Vein Occlusions

IndicationStatusPhase
DBCOND0000674 (Retinal Vein Occlusion)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03056092Cytokine and Visual Outcome Variations in Eyes Receiving RanibizumabTreatment